Horizon’s CEO, Joel White, was a panelist at Jefferies Biotech on the Beach. Joel, alongside John F. Crowley, President of BIO, Raghav Aggarwal, a former Senior Policy Advisor at CMS, and moderator Mike Yee, discussed the evolving landscape in Washington, DC. They delved into the shifting dynamics under the Trump administration and a GOP-led Congress, including the implications for the biotech sector.
